(+)-schisandrin B multiple interactions ISO RGD:1311155 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IL33 mRNA] CTD PMID:31150632 (S)-nicotine multiple interactions ISO RGD:1322461 6480464 Nicotine promotes the reaction [Lipopolysaccharides results in increased secretion of IL33 protein] CTD PMID:29673796 (S)-nicotine increases secretion ISO RGD:1322461 6480464 Nicotine results in increased secretion of IL33 protein CTD PMID:29673796 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO RGD:1322461 6480464 2 more ... CTD PMID:30017638 1-naphthyl isothiocyanate decreases expression ISO RGD:1311155 6480464 1-Naphthylisothiocyanate results in decreased expression of IL33 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:1322461 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IL33 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol multiple interactions EXP 6480464 Estradiol promotes the reaction [Toluene 2, 4-Diisocyanate results in increased expression of IL33 protein] CTD PMID:30017638 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IL33 mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1311155 6480464 [3 more ... CTD PMID:16984957 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IL33 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322461 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL33 mRNA alternative form], Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to IL33 promoter] CTD PMID:31093659 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322461 6480464 Tetrachlorodibenzodioxin results in increased expression of IL33 mRNA alternative form CTD PMID:31093659 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1311155 6480464 Tetrachlorodibenzodioxin results in decreased expression of IL33 mRNA CTD PMID:18178546 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IL33 mRNA CTD PMID:21570461 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of IL33 mRNA CTD PMID:17317680 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:1311155 6480464 Glucosamine results in decreased expression of IL33 mRNA CTD PMID:17109745 2-hydroxypropanoic acid increases expression ISO RGD:1322461 6480464 Lactic Acid results in increased expression of IL33 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1311155 6480464 [3 more ... CTD PMID:16984957 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1311155 6480464 3 more ... CTD PMID:16984957 , PMID:20959002 3-chloropropane-1,2-diol decreases expression ISO RGD:1311155 6480464 alpha-Chlorohydrin results in decreased expression of IL33 mRNA CTD PMID:28522335 3H-1,2-dithiole-3-thione decreases expression ISO RGD:1311155 6480464 1, 2-dithiol-3-thione results in decreased expression of IL33 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1311155 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of IL33 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of IL33 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of IL33 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO RGD:1311155 6480464 Propylthiouracil results in increased expression of IL33 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO RGD:1311155 6480464 9 more ... CTD PMID:19480007 acrylamide decreases expression ISO RGD:1311155 6480464 Acrylamide results in decreased expression of IL33 mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IL33 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1322461 6480464 Aflatoxin B1 results in decreased methylation of IL33 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1322461 6480464 Aflatoxin B1 results in increased expression of IL33 mRNA CTD PMID:21641981 aldehydo-D-glucosamine decreases expression ISO RGD:1311155 6480464 Glucosamine results in decreased expression of IL33 mRNA CTD PMID:17109745 all-trans-retinoic acid multiple interactions EXP 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of IL33 mRNA CTD PMID:30951980 amiodarone affects expression ISO RGD:1311155 6480464 Amiodarone affects the expression of IL33 mRNA CTD PMID:18355885 amitriptyline affects expression ISO RGD:1311155 6480464 Amitriptyline affects the expression of IL33 mRNA CTD PMID:18355885 antirheumatic drug decreases expression ISO RGD:1322461 6480464 Antirheumatic Agents results in decreased expression of IL33 CTD PMID:20472598 Aroclor 1254 decreases expression ISO RGD:1311155 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of IL33 mRNA CTD PMID:18178546 avobenzone increases expression ISO RGD:1322461 6480464 avobenzone results in increased expression of IL33 mRNA CTD PMID:31016361 beta-D-glucosamine decreases expression ISO RGD:1311155 6480464 Glucosamine results in decreased expression of IL33 mRNA CTD PMID:17109745 bis(2-chloroethyl) sulfide affects expression ISO RGD:1311155 6480464 Mustard Gas affects the expression of IL33 mRNA CTD PMID:15651846 bisphenol A affects expression ISO RGD:1311155 6480464 bisphenol A affects the expression of IL33 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 bisphenol A promotes the reaction [Ovalbumin results in increased expression of and results in increased secretion of IL33 protein] more ... CTD PMID:29737898 , PMID:29846729 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IL33 mRNA CTD PMID:30951980 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of IL33 mRNA CTD PMID:30951980 C60 fullerene decreases expression ISO RGD:1311155 6480464 fullerene C60 results in decreased expression of IL33 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:1311155 6480464 Cadmium Chloride results in increased expression of IL33 mRNA CTD PMID:25993096 cadmium sulfate multiple interactions EXP 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of IL33 mRNA] CTD PMID:16221973 calcitriol increases expression ISO RGD:1322461 6480464 Calcitriol results in increased expression of IL33 mRNA CTD PMID:26485663 carbon nanotube increases expression ISO RGD:1322461 6480464 Nanotubes, Carbon results in increased expression of IL33 mRNA CTD PMID:25511174 carbon nanotube increases secretion EXP 6480464 Nanotubes, Carbon results in increased secretion of IL33 protein CTD PMID:19371758 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of IL33 mRNA, Nanotubes, Carbon results in increased expression of IL33 mRNA CTD PMID:22293422 , PMID:25554681 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of IL33 mRNA CTD PMID:23125180 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of IL33 mRNA CTD PMID:28472532 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of IL33 protein CTD PMID:21949094 cisplatin multiple interactions ISO RGD:1322461 6480464 [Cisplatin co-treated with IL33] results in increased expression of CXCL1, CD4 mutant form inhibits the reaction [[Cisplatin co-treated with IL33] results in increased expression of CXCL1] CTD PMID:21949094 clomipramine affects expression ISO RGD:1311155 6480464 Clomipramine affects the expression of IL33 mRNA CTD PMID:18355885 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IL33 mRNA CTD PMID:15467011 copper atom increases expression ISO RGD:1311155 6480464 Copper results in increased expression of IL33 mRNA CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IL33 mRNA CTD PMID:15467011 copper(0) increases expression ISO RGD:1311155 6480464 Copper results in increased expression of IL33 mRNA CTD PMID:30556269 crocidolite asbestos increases expression ISO RGD:1322461 6480464 Asbestos, Crocidolite results in increased expression of IL33 mRNA CTD PMID:25757056 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of IL33 mRNA, deoxynivalenol results in increased expression of IL33 protein CTD PMID:26304032 deoxynivalenol multiple interactions EXP 6480464 Oligosaccharides analog inhibits the reaction [deoxynivalenol results in increased expression of IL33 mRNA], Oligosaccharides analog inhibits the reaction [deoxynivalenol results in increased expression of IL33 protein] CTD PMID:26304032 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of IL33 mRNA CTD PMID:22733784 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of IL33 mRNA CTD PMID:26934552 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of IL33 mRNA CTD PMID:26934552 diuron decreases expression ISO RGD:1311155 6480464 Diuron results in decreased expression of IL33 mRNA CTD PMID:21551480 , PMID:25152437 diuron increases expression ISO RGD:1322461 6480464 Diuron metabolite results in increased expression of IL33 mRNA CTD PMID:24172598 doxorubicin decreases expression ISO RGD:1322461 6480464 Doxorubicin results in decreased expression of IL33 mRNA CTD PMID:29803840 endosulfan affects expression ISO RGD:1311155 6480464 Endosulfan affects the expression of IL33 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:1311155 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of IL33 mRNA CTD PMID:17347304 ethanol affects expression EXP 6480464 Ethanol affects the expression of IL33 mRNA CTD PMID:30319688 ferulic acid multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL33 mRNA] CTD PMID:31054998 flutamide decreases expression ISO RGD:1311155 6480464 Flutamide results in decreased expression of IL33 mRNA CTD PMID:24136188 , PMID:24793618 folic acid multiple interactions ISO RGD:1322461 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of IL33 mRNA CTD PMID:22975265 formaldehyde decreases expression ISO RGD:1322461 6480464 Formaldehyde results in decreased expression of IL33 mRNA CTD PMID:27664576 fragrance decreases expression ISO RGD:1322461 6480464 Perfume results in decreased expression of IL33 mRNA CTD PMID:24768652 furan increases methylation ISO RGD:1311155 6480464 furan results in increased methylation of IL33 gene CTD PMID:22079235 glutathione increases expression ISO RGD:1311155 6480464 Glutathione deficiency results in increased expression of IL33 mRNA CTD PMID:20621112 glyphosate multiple interactions EXP 6480464 IL13 protein affects the reaction [glyphosate results in increased expression of IL33 protein] CTD PMID:25172162 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of IL33 protein CTD PMID:25172162 hydroquinone decreases expression ISO RGD:1322461 6480464 hydroquinone results in decreased expression of IL33 mRNA CTD PMID:31256213 imipramine affects expression ISO RGD:1311155 6480464 Imipramine affects the expression of IL33 mRNA CTD PMID:18355885 imiquimod multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL33 mRNA] CTD PMID:31054998 imiquimod increases expression EXP 6480464 Imiquimod results in increased expression of IL33 mRNA CTD PMID:31054998 indole-3-methanol affects expression ISO RGD:1311155 6480464 indole-3-carbinol affects the expression of IL33 mRNA CTD PMID:21396975 ketoconazole affects expression ISO RGD:1311155 6480464 Ketoconazole affects the expression of IL33 mRNA CTD PMID:18355885 leflunomide decreases expression ISO RGD:1311155 6480464 leflunomide results in decreased expression of IL33 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:1322461 6480464 [Lipopolysaccharides co-treated with 4 more ... CTD PMID:29673796 , PMID:30445053 lipopolysaccharide increases secretion ISO RGD:1322461 6480464 Lipopolysaccharides results in increased secretion of IL33 protein CTD PMID:29673796 mercury atom decreases expression EXP 6480464 Mercury analog results in decreased expression of IL33 mRNA CTD PMID:25056781 mercury(0) decreases expression EXP 6480464 Mercury analog results in decreased expression of IL33 mRNA CTD PMID:25056781 methoxychlor multiple interactions EXP 6480464 Methoxychlor promotes the reaction [Toluene 2, 4-Diisocyanate results in increased expression of IL33 protein] CTD PMID:30017638 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of IL33 mRNA CTD PMID:24535843 N-nitrosodimethylamine decreases expression ISO RGD:1311155 6480464 Dimethylnitrosamine results in decreased expression of IL33 mRNA CTD PMID:25380136 N-nitrosomorpholine decreases expression ISO RGD:1311155 6480464 N-nitrosomorpholine results in decreased expression of IL33 mRNA CTD PMID:19716841 nefazodone decreases expression ISO RGD:1311155 6480464 nefazodone results in decreased expression of IL33 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1322461 6480464 Nickel results in decreased expression of IL33 mRNA CTD PMID:24768652 nicotine multiple interactions ISO RGD:1322461 6480464 Nicotine promotes the reaction [Lipopolysaccharides results in increased secretion of IL33 protein] CTD PMID:29673796 nicotine increases secretion ISO RGD:1322461 6480464 Nicotine results in increased secretion of IL33 protein CTD PMID:29673796 orphenadrine affects expression ISO RGD:1311155 6480464 Orphenadrine affects the expression of IL33 mRNA CTD PMID:23665939 oxaliplatin multiple interactions ISO RGD:1311155 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL33 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:1311155 6480464 oxaliplatin results in increased expression of IL33 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of IL33 mRNA CTD PMID:17095637 ozone multiple interactions EXP 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of IL33 mRNA, LEP protein affects the reaction [Ozone results in increased expression of IL33 protein] CTD PMID:25658374 , PMID:27472835 ozone increases expression EXP 6480464 Ozone results in increased expression of IL33 protein CTD PMID:27472835 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of IL33 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1322461 6480464 Acetaminophen results in decreased expression of IL33 mRNA CTD PMID:27761495 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of IL33 mRNA CTD PMID:28012437 pemetrexed multiple interactions ISO RGD:1322461 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of IL33 mRNA CTD PMID:22975265 pentanal increases expression ISO RGD:1322461 6480464 pentanal results in increased expression of IL33 mRNA CTD PMID:26079696 pentane-2,3-dione increases expression ISO RGD:1311155 6480464 2, 3-pentanedione results in increased expression of IL33 mRNA CTD PMID:25710175 pentane-2,3-dione decreases expression ISO RGD:1322461 6480464 2, 3-pentanedione results in decreased expression of IL33 mRNA CTD PMID:30710127 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1322461 6480464 perfluorooctane sulfonic acid results in decreased expression of IL33 mRNA CTD PMID:27153767 perfluorooctanoic acid decreases expression ISO RGD:1311155 6480464 perfluorooctanoic acid results in decreased expression of IL33 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:1311155 6480464 Phenobarbital results in decreased expression of IL33 mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO RGD:1311155 6480464 pirinixic acid results in decreased expression of IL33 mRNA CTD PMID:19162173 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IL33 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of IL33 mRNA CTD PMID:17426115 , PMID:20813756 poly(I:C) multiple interactions ISO RGD:1322461 6480464 2 more ... CTD PMID:30017638 poly(I:C) increases expression ISO RGD:1322461 6480464 Poly I-C results in increased expression of IL33 protein CTD PMID:30017638 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of IL33 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1311155 6480464 Pregnenolone Carbonitrile results in decreased expression of IL33 mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:1322461 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of IL33 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of IL33 mRNA CTD PMID:17404688 , PMID:20660070 progesterone increases expression ISO RGD:1311155 6480464 Progesterone results in increased expression of IL33 mRNA CTD PMID:21770760 progesterone decreases expression ISO RGD:1322461 6480464 Progesterone results in decreased expression of IL33 mRNA CTD PMID:17404688 quinazolines multiple interactions ISO RGD:1322461 6480464 Quinazolines inhibits the reaction [IL33 protein results in increased expression of CXCL8 mRNA] more ... CTD PMID:23585867 rac-lactic acid increases expression ISO RGD:1322461 6480464 Lactic Acid results in increased expression of IL33 mRNA CTD PMID:30851411 silicon dioxide increases expression ISO RGD:1322461 6480464 Silicon Dioxide analog results in increased expression of IL33 mRNA CTD PMID:23806026 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of IL33 mRNA CTD PMID:23221170 sodium dichromate increases expression ISO RGD:1311155 6480464 sodium bichromate results in increased expression of IL33 mRNA CTD PMID:22561333 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of IL33 mRNA CTD PMID:22155349 sulforaphane decreases expression EXP 6480464 sulforafan results in decreased expression of IL33 mRNA CTD PMID:30529165 Tesaglitazar decreases expression ISO RGD:1311155 6480464 tesaglitazar results in decreased expression of IL33 mRNA CTD PMID:21515302 tetrachloromethane decreases expression ISO RGD:1311155 6480464 Carbon Tetrachloride results in decreased expression of IL33 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1311155 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IL33 mRNA] CTD PMID:31150632 thioacetamide decreases expression ISO RGD:1311155 6480464 Thioacetamide results in decreased expression of IL33 mRNA CTD PMID:23411599 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of IL33 mRNA CTD PMID:23409001 more ... titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of IL33 mRNA CTD PMID:29264374 toluene decreases expression ISO RGD:1311155 6480464 Toluene results in decreased expression of IL33 mRNA CTD PMID:22967744 toluene 2,4-diisocyanate multiple interactions EXP 6480464 4 more ... CTD PMID:29846729 more ... toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2, 4-Diisocyanate results in increased expression of IL33 protein CTD PMID:30017638 topotecan multiple interactions ISO RGD:1311155 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IL33 mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:1311155 6480464 Topotecan results in increased expression of IL33 mRNA CTD PMID:25729387 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of IL33 protein CTD PMID:26048654 triclosan decreases expression ISO RGD:1322461 6480464 Triclosan results in decreased expression of IL33 protein CTD PMID:26048654 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of IL33 mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1311155 6480464 troglitazone results in increased expression of IL33 mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:1322461 6480464 Valproic Acid results in decreased methylation of IL33 gene CTD PMID:29154799 vinclozolin affects expression ISO RGD:1311155 6480464 vinclozolin affects the expression of IL33 mRNA CTD PMID:19015723 Vinpocetine multiple interactions EXP 6480464 vinpocetine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL33 protein] CTD PMID:25980587 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of IL33 mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:1311155 6480464 squalestatin 1 results in decreased expression of IL33 mRNA CTD PMID:27225895
Biological Process defense response to virus IDA 2290270 (MGI:MGI:5543337, PMID:23630360) MGI MGI:MGI:5543337 , PMID:23630360 extrinsic apoptotic signaling pathway IGI MGI:MGI:99695 2290270 (MGI:MGI:5437589, PMID:22660580) MGI MGI:MGI:5437589 , PMID:22660580 macrophage activation involved in immune response IDA 2290270 (MGI:MGI:5751675, PMID:21494550) UniProtKB MGI:MGI:5751675 , PMID:21494550 microglial cell activation involved in immune response IDA 2290270 (MGI:MGI:5008219, PMID:21349253) UniProtKB MGI:MGI:5008219 , PMID:21349253 microglial cell proliferation IDA 2290270 (MGI:MGI:5008219, PMID:21349253) UniProtKB MGI:MGI:5008219 , PMID:21349253 negative regulation of immunoglobulin secretion IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 negative regulation of interferon-gamma production IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 negative regulation of leukocyte migration IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 negative regulation of T-helper 1 type immune response IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 obsolete interaction with symbiont via secreted substance ISO UniProtKB:O95760 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 obsolete interaction with symbiont via secreted substance IDA 2290270 (MGI:MGI:6141045, PMID:29045903) UniProt MGI:MGI:6141045 , PMID:29045903 positive regulation of chemokine secretion IDA 2290270 (MGI:MGI:4430159, PMID:19841166) BHF-UCL MGI:MGI:4430159 , PMID:19841166 positive regulation of chemokine secretion ISO UniProtKB:O95760 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 positive regulation of gene expression IDA 2290270 (MGI:MGI:4355633, PMID:19666510) MGI MGI:MGI:4355633 , PMID:19666510 positive regulation of immunoglobulin secretion IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 positive regulation of inflammatory response IDA 2290270 (MGI:MGI:4430159, PMID:19841166) BHF-UCL MGI:MGI:4430159 , PMID:19841166 positive regulation of inflammatory response IBA MGI:MGI:1924375 , PANTHER:PTN000473807 2290270 (PMID:21873635) GO_Central PMID:21873635 positive regulation of interleukin-13 production IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 positive regulation of interleukin-4 production IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 positive regulation of interleukin-5 production IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 positive regulation of interleukin-6 production IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 positive regulation of macrophage activation IDA 2290270 (MGI:MGI:4430159, PMID:19841166) BHF-UCL MGI:MGI:4430159 , PMID:19841166 positive regulation of macrophage activation ISO UniProtKB:O95760 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 positive regulation of proteasomal ubiquitin-dependent protein catabolic process IDA 2290270 (MGI:MGI:5437589, PMID:22660580) MGI MGI:MGI:5437589 , PMID:22660580 positive regulation of proteasomal ubiquitin-dependent protein catabolic process IGI MGI:MGI:1861437 , MGI:MGI:3039600 2290270 (MGI:MGI:5437589, PMID:22660580) MGI MGI:MGI:5437589 , PMID:22660580 positive regulation of transcription by RNA polymerase II IDA 2290270 (MGI:MGI:4430159, PMID:19841166) BHF-UCL MGI:MGI:4430159 , PMID:19841166 positive regulation of type 2 immune response IGI UniProtKB:P08226 2290270 (MGI:MGI:3775141, PMID:18268038) BHF-UCL MGI:MGI:3775141 , PMID:18268038 positive regulation of type 2 immune response IDA 2290270 (MGI:MGI:5543337, PMID:23630360) MGI MGI:MGI:5543337 , PMID:23630360 Cellular Component chromosome IEA UniProtKB-KW:KW-0158 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 cytoplasmic vesicle IEA UniProtKB-KW:KW-0968 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 extracellular region IEA UniProtKB-KW:KW-0964 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 extracellular space IEA UniProtKB-KW:KW-0202 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 nucleus ISO EMBL:AB024518 2290270 (MGI:MGI:2665245, PMID:12819012) MGI MGI:MGI:2665245 , PMID:12819012 nucleus IDA 2290270 (MGI:MGI:6141045, PMID:29045903) UniProt MGI:MGI:6141045 , PMID:29045903 Molecular Function cytokine activity IDA 2290270 (MGI:MGI:4430159, PMID:19841166) BHF-UCL MGI:MGI:4430159 , PMID:19841166 cytokine activity IBA MGI:MGI:1924375 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 cytokine activity ISO UniProtKB:O95760 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 cytokine activity IPI UniProtKB:P14719-1 , UniProtKB:P14719-2 2290270 (MGI:MGI:3723275, PMID:17623648) MGI MGI:MGI:3723275 , PMID:17623648 interleukin-33 receptor binding IPI UniProtKB:P14719 2290270 (MGI:MGI:6141045, PMID:29045903) UniProt MGI:MGI:6141045 , PMID:29045903 protein binding IPI UniProtKB:A0A3P7XL18 2290270 (MGI:MGI:6141045, PMID:29045903) UniProt MGI:MGI:6141045 , PMID:29045903
Gene-Chemical Interaction Annotations
